One-Third Of Antimalarial Medicines Sampled In 3 African Nations Found To Be Substandard
The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria…
More: continued here
Filed under: MRSA / Drug Resistance on February 11th, 2010
You must be logged in to post a comment.